Literature DB >> 7697237

Resistance of the alveolar epithelium to injury from septic shock in sheep.

J F Pittet1, J P Wiener-Kronish, V Serikov, M A Matthay.   

Abstract

Experimentally, the intravenous administration of a bolus dose of Escherichia coli endotoxin in sheep or a bolus dose of live Pseudomonas aeruginosa in rats is insufficient to cause injury to the alveolar epithelial barrier. Therefore, the first objective of these studies was to maximize the injury caused by live bacteria to the lung by administering a large dose of live P. aeruginosa into the lung perfusate of goat lungs in situ. P. aeruginosa (2.4 x 10(10) colony-forming units [cfu]) and [131I]albumin (vascular protein tracer) were added to the lung perfusate. Even though the bacterial inoculum remained very high in this isolated perfused lung system, there was no change in the permeability to protein or clearance of fluid across the alveolar epithelium, although there was an increase in lung endothelial protein permeability. Therefore, since systemic factors have been implicated in the severity and pathogenesis of septic lung injury, the second objective was to administer a continuous intravenous infusion of live P. aeruginosa over 8 h in intact anesthetized sheep. The eight sheep so treated exhibited an intact, functional alveolar barrier, even though there was an increase in lung endothelial permeability to protein and an increase in extravascular lung water. In fact, in these eight sheep, alveolar epithelial fluid transport was significantly greater than in control sheep. In the three other septic sheep there was injury to the alveolar epithelial barrier with an increase in permeability of the barrier to protein, an inability to transport fluid out of the airspaces, and an even greater increase in extravascular lung water.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7697237     DOI: 10.1164/ajrccm.151.4.7697237

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  14 in total

Review 1.  Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium.

Authors:  Y Berthiaume; O Lesur; A Dagenais
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

2.  The biphasic immunoregulation of pyrimidylpiperazine (Y-40138) is IL-10 sensitive and requires NF-kappa B targeting in the alveolar epithelium.

Authors:  J J Haddad; B Safieh-Garabedian; N E Saadé; S C Land
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

3.  Inhibition of NADPH oxidase prevents acute lung injury in obese rats following severe trauma.

Authors:  Lusha Xiang; Silu Lu; Peter N Mittwede; John S Clemmer; Robert L Hester
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

Review 4.  Human epidermal growth factor receptor signaling in acute lung injury.

Authors:  James H Finigan; Gregory P Downey; Jeffrey A Kern
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-31       Impact factor: 6.914

5.  Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury.

Authors:  James H Finigan; Jihane A Faress; Emily Wilkinson; Rangnath S Mishra; David E Nethery; David Wyler; Mohammad Shatat; Lorraine B Ware; Michael A Matthay; Robert Mason; Richard F Silver; Jeffrey A Kern
Journal:  J Biol Chem       Date:  2011-01-19       Impact factor: 5.157

Review 6.  Mechanisms of bacterial virulence in pulmonary infections.

Authors:  Samuel M Moskowitz; Jeanine P Wiener-Kronish
Journal:  Curr Opin Crit Care       Date:  2010-02       Impact factor: 3.687

7.  Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice.

Authors:  Jennifer M Scarff; Joanna B Goldberg
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

8.  Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials.

Authors:  Ashish Agrawal; Hanjing Zhuo; Sandra Brady; Joseph Levitt; Jay Steingrub; Mark D Siegel; Graciela Soto; Michael W Peterson; Mark S Chesnutt; Michael A Matthay; Kathleen D Liu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-03       Impact factor: 5.464

Review 9.  Alveolar edema fluid clearance and acute lung injury.

Authors:  Yves Berthiaume; Michael A Matthay
Journal:  Respir Physiol Neurobiol       Date:  2007-05-21       Impact factor: 1.931

10.  Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response.

Authors:  Laurent Robriquet; François Collet; Antoine Tournoys; Thierry Prangère; Rémi Nevière; François Fourrier; Benoît P Guery
Journal:  Respir Res       Date:  2006-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.